Compare NEOG & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NEOG | ATRC |
|---|---|---|
| Founded | 1981 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.5B |
| IPO Year | 1995 | 2005 |
| Metric | NEOG | ATRC |
|---|---|---|
| Price | $12.09 | $60.06 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 10 |
| Target Price | $14.00 | ★ $57.56 |
| AVG Volume (30 Days) | ★ 3.5M | 665.5K |
| Earning Date | 10-06-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 99.20 | 74.74 |
| EPS | N/A | ★ 0.18 |
| Revenue | ★ $870,400,000.00 | $201,630,000.00 |
| Revenue This Year | $2.03 | $13.42 |
| Revenue Next Year | N/A | $12.20 |
| P/E Ratio | ★ N/A | $332.83 |
| Revenue Growth | N/A | ★ 15.40 |
| 52 Week Low | $5.37 | $25.36 |
| 52 Week High | $14.26 | $63.00 |
| Indicator | NEOG | ATRC |
|---|---|---|
| Relative Strength Index (RSI) | 47.87 | 57.66 |
| Support Level | $11.25 | $26.95 |
| Resistance Level | $12.35 | $61.70 |
| Average True Range (ATR) | 0.43 | 2.00 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 30.22 | 61.74 |
Neogen Corp is develop, manufacture and market a diverse line of products and services dedicated to food and animal safety. Its Food Safety segment consists mainly of diagnostic test kits and complementary products (e.g., culture media) sold to food and animal feed producers and processors to preserve the safety and quality of food to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. These products also ensure the general hygiene of the food manufacturing environment. It also have products to determine food quality and nutritional components. Its segments are Food, Animal safety. Majority of revenue comes from Food Safety. It has presence in United states, and International market.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.